- Lobbying
- ucb
Lobbying Arrangements Results for 'Ucb'
Former Covered Federal Workers:
Other Lobbyists:
Issue | Client | Firm | Lobbyists | Start Date | Latest Filing Date |
---|---|---|---|---|---|
Details H.R. 830 - HELP Copays Act H.R. 5397 - Joe Fiandra Access to Home Infusion Act S. 1375 - HELP Copays Act 340B Drug Pricing Program PBM Reforms Medicaid Drug Rebate Program proposed rule PBM Reforms... |
UCB, Inc.
|
in-house lobbying | |||
Details Issues related to use and reimbursement of pharmacuticals under Medicare/Medicaid. |
UCB, Inc.
|
RICCHETTI INCORPORATED | |||
Details Labor HHS Appropriations FIPSE |
Urban College of Boston (UCB)
|
Moss McGee Bradley, LLC | |||
Details Recognition of outstanding UCB graduate |
Ritz Global Relations
|
ALCALDE & FAY | |||
Details Policies related to biopharmaceutical access and innovation. |
UCB, Inc.
|
VENN STRATEGIES | |||
Details Drug safety and drug counterfeiting including H.R. 579, the Food and Drug Administration Globalization Act; Drug importation including S. 525/H.R. 1298, the Pharmaceutical Market Access and Drug ... |
UCB, Inc.
|
Williams and Jensen, PLLC | |||
Details General Medicare/Medicaid Issues. Prescription drug payment reform. Medicare prescription drug reimbursement. Implementation of Inflation Reduction Act of 2022. HELP Copays Act. FDA Issues. |
UCB, Inc.
|
Todd Strategy Group | |||
Details Work with Congress and the Administration to ensure that the Orphan Drug Exclusion from eligibility for negotiation under the Medicare Drug Price Negotiation Program allows products to remain exclu... |
Save Rare Treatments Task Force
|
Leavitt Partners, LLC | |||
Details Monitored the implementation of P.L. 117-169, the Inflation Reduction Act, as it relates to drug pricing. H.R. 2666, the Medicaid VBPs for Patients (MVP) Act, and issues related to value-based paym... |
UCB, Inc.
|
THE NICKLES GROUP, LLC |